Page last updated: 2024-10-25

dantrolene and Antidiuretic Hormone, Inappropriate Secretion

dantrolene has been researched along with Antidiuretic Hormone, Inappropriate Secretion in 1 studies

Dantrolene: Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants.
dantrolene : The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin. A ryanodine receptor antagonist used for the relief of chronic severe spasticity and malignant hyperthermia.

Research Excerpts

ExcerptRelevanceReference
"Hyponatremia associated with neuroleptic malignant syndrome has thus far been described as a syndrome of inappropriate secretion of antidiuretic hormone."1.34Cerebral salt-wasting syndrome in a patient with neuroleptic malignant syndrome. ( Külkens, S; Lenhard, T; Schwab, S, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lenhard, T1
Külkens, S1
Schwab, S1

Other Studies

1 other study available for dantrolene and Antidiuretic Hormone, Inappropriate Secretion

ArticleYear
Cerebral salt-wasting syndrome in a patient with neuroleptic malignant syndrome.
    Archives of neurology, 2007, Volume: 64, Issue:1

    Topics: Creatine Kinase; Dantrolene; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Middle Aged;

2007